Joseph Group Capital Management increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,748 shares of the pharmaceutical company’s stock after buying an additional 310 shares during […]
Rhenman & Partners Asset Management AB grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,000 shares of the pharmaceutical company’s stock after purchasing an additional […]
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading gene therapy stock to .
Parnassus Investments LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 738 shares of the pharmaceutical company’s stock after purchasing an additional 74 shares during the period. Parnassus Investments LLC’s […]
Condor Capital Management lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,023 shares of the pharmaceutical company’s stock after selling 75 shares during the period. Condor Capital Management’s holdings in Vertex Pharmaceuticals […]